THW
Get informed when a big investor buys or sells
+ FollowOvervalued by 1.6% based on the discounted cash flow analysis.
| Market cap | $520.05 Million |
|---|---|
| Enterprise Value | $640.83 Million |
| Dividend Yield | $1.40 (10.86%) |
| Earnings per Share | $1.43 |
| Beta | 0.83 |
| Outstanding Shares | 38,727,877 |
| P/E Ratio | 9.01 |
|---|---|
| PEG | 6.12 |
| Price to Sales | 6.14 |
| Price to Book Ratio | 0.94 |
| Enterprise Value to Revenue | 7.94 |
| Enterprise Value to EBIT | 4.09 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.24 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 14.75%▼ 2.50% |
|---|---|
| Total Invested | $65.93M▼ 22.78% |
| Investors Holding | 840% |
No data
Tekla World Healthcare Fund is a closed-end fund that invests in companies in the healthcare industry. Tekla Capital Management LLC, based in Boston, serves as investment adviser to the Fund.